Dannex Ayrton Starwin Plc

GHSE:DASPHARMA Stock Report

Market Cap: GH₵0

Dannex Ayrton Starwin Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Daniel Kwabena Kissi

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenureno data
Board average tenure3.1yrs

Recent management updates

Recent updates

CEO

Daniel Kwabena Kissi (57 yo)

no data

Tenure

Mr. Daniel Kwabena Apeagyei Kissi has been Managing Director of Ayrton Drugs Manufacturing Company Ltd. since December 01, 2012 and also it's Chief Executive Officer. He has been Chief Executive Officer an...

Board Members

NamePositionTenureCompensationOwnership
Theophilus Amarteifio
Executive Chairmanno datano datano data
Daniel Kwabena Kissi
CEO & Executive Directorno datano datano data
Henry Ocansey
CFO & Executive Director3.1yrsno datano data
Kwasi Yirenkyi
Chief Corporate Affairs & Communications Officer and Non-Executive Director3.1yrsno datano data
Alex Kwabena Bonney
Non-Executive Directorno datano datano data
Barima Afrane
Non-Executive Directorno datano datano data
Amarteokor Amarteifio
Non-Executive Directorno datano data3.78%
GHS 0
Benjamin Agyeman
Non-Executive Director3.1yrsno datano data
Moritz Acquah
Non-Executive Director2yrsno datano data

3.1yrs

Average Tenure

73yo

Average Age

Experienced Board: DASPHARMA's board of directors are considered experienced (3.1 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/31 08:49
End of Day Share Price 2024/12/27 00:00
EarningsN/A
Annual EarningsN/A

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Dannex Ayrton Starwin Plc is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution